, the only effective drugs for the treatment of tumor syndrome in NF1 are
inhibitors of mitogen
Spasov, AA,
Kucheryavenko, AF,
Khaliullin, FA,
Gurova, NA,
Sirotenko, VS,
Samorodov, AV,
Gaidukova, KA,
Pavlov, VN (2022) administered intravenously was 1.2 times less effective, in terms of ED50, than the well-known
inhibitor methods for diagnosing gliomas, including the search for
novel biomarkers. MicroRNA (miRNAs), a class
. The number of registered trials had gradually increased during the past years.
Novel biological drugs have
, TNFRSF1B are associated with levels of TNF-α, hsCRP.
Novel association of TNFRSF1B (rs1061624) with MetS
of ketotiphen, Lydase and Aevit, as well as monotherapy with an ATP-independent
inhibitor of mitogen